447.09
price up icon0.45%   1.99
pre-market  시장 영업 전:  446.99   -0.10   -0.02%
loading

Vertex Pharmaceuticals Inc 주식(VRTX)의 최신 뉴스

pulisher
May 28, 2025

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today - Benzinga

May 28, 2025
pulisher
May 28, 2025

Harvard Professor to Chief Medical Officer: Wave Life Sciences Taps RNA Expert Behind Breakthrough FDA Approvals - Stock Titan

May 28, 2025
pulisher
May 28, 2025

Great Valley Advisor Group Inc. Raises Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow - AOL.com

May 28, 2025
pulisher
May 27, 2025

Eli Lilly Commits $1B to Get Drug That Could Rival Vertex’s New Non-Opioid Pain Med - MedCity News

May 27, 2025
pulisher
May 27, 2025

Lilly to buy pain drug developer SiteOne, challenging Vertex - BioPharma Dive

May 27, 2025
pulisher
May 27, 2025

Lilly lands next-gen pain asset in $1B SiteOne acquisition - Fierce Biotech

May 27, 2025
pulisher
May 27, 2025

Vertex Pharmaceuticals’ SWOT analysis: cystic fibrosis leader faces diversification challenges - Investing.com

May 27, 2025
pulisher
May 27, 2025

Vertex Pharmaceuticals Stock Outlook: Is Wall Street Bullish or Bearish? - MSN

May 27, 2025
pulisher
May 27, 2025

ViewPoints: Vertex’s triplet data raise bar and turn screws on CF competition - FirstWord Pharma

May 27, 2025
pulisher
May 26, 2025

Vertex divulges new Nav1.8 blockers for pain - BioWorld MedTech

May 26, 2025
pulisher
May 24, 2025

2 Monster Growth Stocks to Buy and Hold for 10 Years - The Motley Fool

May 24, 2025
pulisher
May 23, 2025

Vertex: Continuing To Dominate In CF, But What About Its Pain Pipeline? (NASDAQ:VRTX) - Seeking Alpha

May 23, 2025
pulisher
May 23, 2025

Argus Adjusts Price Target on Vertex Pharmaceuticals to $525 From $550 - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Vertex Pharmaceuticals (VRTX) Downgraded Due to High Inventory L - GuruFocus

May 23, 2025
pulisher
May 22, 2025

Vertex Pharmaceuticals (VRTX) Announces $4 Billion Share Buyback Program - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Gilead and Vertex Pharma named among biotech’s tariff safe havens - MSN

May 22, 2025
pulisher
May 21, 2025

Vertex Pharma announces new share buybacks worth up to $4B - MSN

May 21, 2025
pulisher
May 21, 2025

Vertex Pharmaceuticals Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com

May 21, 2025
pulisher
May 21, 2025

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years - Benzinga

May 20, 2025
pulisher
May 20, 2025

Vertex Pharma stock gains on share buybacks (VRTX:NASDAQ) - Seeking Alpha

May 20, 2025
pulisher
May 19, 2025

Vertex Pharmaceuticals (VRTX) Announces New $4 Billion Stock Rep - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Vertex Pharmaceuticals Authorizes $4 Billion In Additional Share Repurchases - marketscreener.com

May 19, 2025
pulisher
May 19, 2025

August 15th Options Now Available For Vertex Pharmaceuticals (VRTX) - Nasdaq

May 19, 2025
pulisher
May 19, 2025

VRTX Q1 Earnings Call: New Product Launches and Pipeline Progress Amid Revenue Miss - Yahoo Finance

May 19, 2025
pulisher
May 15, 2025

Vertex to Participate in Upcoming Investor Conferences | VRTX Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Vertex to Participate in Upcoming Investor Conferences - Business Wire

May 15, 2025
pulisher
May 14, 2025

Vertex Pharmaceuticals Holds Annual Shareholder Meeting - TipRanks

May 14, 2025
pulisher
May 14, 2025

Stifel maintains hold on Vertex stock with $494 target - Investing.com

May 14, 2025
pulisher
May 13, 2025

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today - Benzinga

May 13, 2025
pulisher
May 13, 2025

Best Biotech Stocks to Buy in 2025 - MarketBeat

May 13, 2025
pulisher
May 13, 2025

Fund Update: TRILLIUM ASSET MANAGEMENT, LLC added 38,854 shares of VERTEX PHARMACEUTICALS ($VRTX) to their portfolio - Nasdaq

May 13, 2025
pulisher
May 12, 2025

Our future journey in cystic fibrosis - Vertex Pharmaceuticals

May 12, 2025
pulisher
May 11, 2025

Vertex says late-stage studies of VX-659 triple combination therapy in CF hit main goals - FirstWord Pharma

May 11, 2025
pulisher
May 11, 2025

ViewPoints: Vertex settles on a dynastic successor - FirstWord Pharma

May 11, 2025
pulisher
May 11, 2025

Vertex's VX-445 triple combination regimen achieves main goals of two late-stage studies in CF - FirstWord Pharma

May 11, 2025
pulisher
May 11, 2025

Vertex moves forward with regulatory filings after selecting VX-445 for triple-combination regimen in CF - FirstWord Pharma

May 11, 2025
pulisher
May 11, 2025

Is Vertex Pharmaceuticals (VRTX) Among the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies? - Insider Monkey

May 11, 2025
pulisher
May 11, 2025

Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio? - Benzinga

May 11, 2025
pulisher
May 10, 2025

VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations - MSN

May 10, 2025
pulisher
May 09, 2025

Final Trades: Vertex Pharma, Palantir, Wynn Resorts and Microsoft - CNBC

May 09, 2025
pulisher
May 09, 2025

Vertex Pharmaceuticals Incorporated (VRTX) Surged On a Recovery in Investor Sentiment - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Vertex Pharmaceuticals Incorporated Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Vertex Pharmaceuticals Topples 10% On A Series Of First-Quarter Setbacks - MSN

May 09, 2025
pulisher
May 08, 2025

Vertex Pharma extends selloff as Wolfe downgrades after Q1 miss - MSN

May 08, 2025
pulisher
May 08, 2025

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025
pulisher
May 07, 2025

Vertex Says 20,000 Prescriptions Filled for Non-Opioid Pain Drug - MSN

May 07, 2025
$1.30
price up icon 0.00%
$605.39
price up icon 2.29%
$77.49
price up icon 4.82%
$4.64
price up icon 6.67%
$292.90
price up icon 2.57%
자본화:     |  볼륨(24시간):